Search

everythinglearnresearchcommunity

for

Search:↓

The composition with carnitine, thioctic acid, and saw palmetto extract may effectively reduce inflammation in hair follicle cells.

COVID-19 might worsen symptoms and progression of benign prostatic hyperplasia, possibly due to inflammation and metabolic disturbances in the prostate gland. More research is needed to confirm this.

Hormonal therapies help treat female hair loss, but results are slow and vary.

Both dutasteride and finasteride improve urinary symptoms, but dutasteride may be better at reducing the risk of prostate surgery and sudden inability to urinate.

The new progesterone derivatives effectively inhibit 5α-reductase and bind to the androgen receptor.

COVID-19 can cause various skin issues, like rashes and lesions, which are more common in younger patients and can be linked to more severe complications.

Women with AGA have more androstenedione and dihydrotestosterone, less copper and zinc; copper imbalance affects AGA; treatment improves hormones and minerals.

Animal models are crucial for learning about hair loss and finding treatments.

Hormonal changes during and after pregnancy can cause hair growth changes and hair loss, with treatments available for some conditions.

Some treatments can stabilize Frontal Fibrosing Alopecia, but more research is needed to find effective treatments, and hair transplants often fail.

Dutasteride caused more penile tissue changes than finasteride, possibly increasing erectile dysfunction risk.

New hormonal treatments for enlarged prostate show promise for safer, effective non-surgical options.

Low-dose oral minoxidil effectively reduces hair loss in women with female pattern hair loss.

After menopause, some women lose scalp hair and gain facial hair, with patterns suggesting different underlying causes.

Finasteride effectively treats male hair loss, increasing length and thickness.

Hormonal imbalances may play a role in frontal fibrosing alopecia, and antiandrogenic drugs combined with steroids are currently the most effective treatment.

Minoxidil, finasteride, and low-level laser light therapy are effective FDA-approved treatments for hair loss.

Finasteride for hair loss may cause lasting sexual, genitourinary, mental, and anti-androgenic side effects in young men.

The conclusion is that more hair loss (androgenetic alopecia) is linked to larger prostate size, suggesting hair loss could be an early sign of benign prostatic hyperplasia.

Finasteride use during early pregnancy may cause limb deformities in babies.

Certain drugs, especially antiandrogens and spironolactone, significantly increase the risk of gynecomastia.

Dutasteride can stabilize hair loss in patients with frontal fibrosing alopecia, but its safety in women is unclear, so use it with caution.

Italian guidelines recommend using trichoscopy for diagnosis and treatments like minoxidil for hair loss.

Early diagnosis and combination therapy, especially with finasteride and dutasteride, are key to managing Frontal Fibrosing Alopecia effectively.

The letter is skeptical about the effectiveness of anti-androgen therapy for COVID-19 and calls for strong evidence from clinical trials.

Men with a certain baldness pattern at age 40-50 may have a higher risk of aggressive prostate cancer.

Finasteride 1mg linked to diverse symptoms; other treatments improve erectile function in rats.

New oral treatment, finasteride, effectively and safely treats common hair loss.

Finasteride may worsen blood sugar control in diabetic patients.

Saw palmetto may cause erectile dysfunction and needs better safety monitoring.